Sharing Data and Specimens


When research findings are shared broadly with investigators in the research community, it leads to discoveries that deepen the understanding of disease and improve treatment options for patients. Equitable data sharing balances data accessibility with the rights of the patients who allow their data to be used and reused to catalyze discovery.

To further advance and accelerate research to benefit the public health, data developed in the NIH Intramural Research Program (IRP) (NIH-owned or jointly-owned) should be collected in a manner that permits and promotes the broadest sharing possible. NIH IRP investigators are expected to broadly share data for secondary research purposes consistent with applicable laws, regulations, and policies. Data sharing may be limited, in certain cases, by agreements with outside collaborators, e.g., Cooperative Research and Development Agreements (CRADAs), Clinical Trial Agreements, or other agreements.

Guidance Regarding Data Sharing

There are Currently No Attachments



FAQs


Additional Resources 

  • NIH Genomic Data Sharing Policy 
  • NIH Data Sharing Policy
  • OHSRP Education Series Presentation: When IRB Approval is Necessary and How to Complete the New Investigator Attestation for Tech Transfer Agreements (3/18/19) Slides and Videocast
  • Investigator Attestation: Addressing the Protection of Human Subjects for MTAs/DTAs (OHSRP, 3/19/19)
  • Using or Sharing Data or Biospecimens for Research: When is IRB Approval Needed? (OHSRP, 4/13/20)